Clinical trial
Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia…
NCT00075010 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00075010 |
|---|---|
| Title | Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes |
| Official title | Phase I/II Study of 5-aza-2'-Deoxycytidine and Valproic Acid in Patients With Relapsed/Refractory Leukemia or Myelodysplastic Syndromes |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Eisai Inc. Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Myelodysplastic Syndromes |
| Intervention type | Drug |
| Interventions | Decitabine, Valproic acid |
| Enrollment | 54 |
| Start date | Jan 23, 2004 |
| Primary completion | Nov 8, 2006 |
| Completion | Nov 8, 2006 |
| First posted | Dec 31, 2003 |
| Last update posted | Nov 15, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: